Colgate-Palmolive reported third-quarter results, with revenue of $5.4 billion and statutory earnings per share of $0.94. Analysts subsequently raised their 2027 earnings forecasts, and the share price rebounded. The later outlook calls for 2027 revenue of $21.9 billion and EPS of $4.05. The price target remains $102, but the high and low estimates range from $88 to $112.
Colgate-Palmolive reported revenue of $5.4 billion and statutory earnings per share of $0.94 in its latest earnings release, and its share price rose 4.7% to $97.43 after the announcement. Analysts typically update their forecasts after each earnings release, so the latest figures may have changed the market's assessment.
Following the results, 18 analysts forecast 2027 revenue of $21.9 billion and EPS of $4.05. This suggested a slight improvement in revenue growth compared with the past 12 months. However, while EPS was revised upward from the previous forecast, the change to the revenue forecast was limited.
The consensus price target remains $102, with no significant change, and ranges from a high of $112 to a low of $88. Revenue growth is forecast at an annual rate of 2.3% through the end of 2027, compared with an average growth rate of 4.2% over the past 5 years and approximately 3.0% for peers, suggesting a slowdown in growth.